A detailed history of Spectrum Management Group, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Spectrum Management Group, LLC holds 35 shares of ADPT stock, worth $223. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35
Holding current value
$223
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

BUY
$6.5 - $12.67 $227 - $443
35 New
35 $0
Q2 2020

Aug 11, 2020

BUY
$24.95 - $48.38 $873 - $1,693
35 New
35 $2,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $913M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Spectrum Management Group, LLC Portfolio

Follow Spectrum Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spectrum Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spectrum Management Group, LLC with notifications on news.